Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions.
about
Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrolThe dimeric structure of Sulfolobus solfataricus thioredoxin A2 and the basis of its thermostabilitySelenium and its supplementation in cardiovascular disease--what do we know?The mechanism whereby heat shock induces apoptosis depends on the innate sensitivity of cells to stress.Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.Identification of anhydrobiosis-related genes from an expressed sequence tag database in the cryptobiotic midge Polypedilum vanderplanki (Diptera; Chironomidae).Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients.Functional recovery of diabetic mouse hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO-signaling network.PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.Regulation and function of selenoproteins in human diseaseEffect of specific activation of γ-aminobutyric acid receptor in vivo on oxidative stress-induced damage after extended hepatectomy.Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice.Redox control of renal function and hypertension.Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo.High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferationPretreatment of Small-for-Size Grafts In Vivo by γ -Aminobutyric Acid Receptor Regulation against Oxidative Stress-Induced Injury in Rat Split Orthotopic Liver TransplantationModulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequenceLiver graft pretreated in vivo or ex vivo by γ-aminobutyric acid receptor regulation.Pretreatment of liver grafts in vivo by γ-aminobutyric acid receptor regulation reduces cold ischemia/warm reperfusion injury in rat.Oxidative stress and extracellular matrices after hepatectomy and liver transplantation in ratsImpact of dietary selenium intake on cardiac health: experimental approaches and human studies.Cytotoxicity induced by inhibition of thioredoxin reductases via multiple signaling pathways: role of cytosolic phospholipase A(2)alpha-dependent and -independent release of arachidonic acid.Arsenic Induces Thioredoxin 1 and Apoptosis in Human Liver HHL-5 Cells.The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1.Purification and biochemical characterization of an organic-solvent-tolerant thioredoxin from dromedary pancreas.Determination of antimutagenic properties of apigenin-7-O-rutinoside, a flavonoid isolated from Mentha longifolia (L.) Huds. ssp. longifolia with yeast DEL assay.Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain.The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?Selenoproteins and cardiovascular stress.Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats.Genetic polymorphisms in the thioredoxin 2 (TXN2) gene and risk for spina bifida.
P2860
Q26999376-3E585890-9324-4BF6-8AB5-773E26B39DA5Q27657486-D5D824D4-97ED-432A-8B4B-35CD47019DC1Q28084516-DD34C630-5CA9-4DDA-86DB-9D1859BE4C10Q30494400-1C2532D6-F368-4C48-A809-EB6573920F50Q33649846-5F0095F5-6765-43B0-9DB9-6C66C0B1246BQ33690382-DAFB0E7A-AC20-4F25-9621-872ED61EBF6AQ33724682-D12BED63-573F-49F7-9BFA-A75E6978FCAAQ33778090-B92D550C-E6D4-4F1B-BF39-85F6F5A06F93Q33931451-C757F22A-6073-489C-86CA-7394B20F3A3FQ34029071-BBF37F79-E433-4A20-99D5-E124E68437CBQ36223599-B72776C9-C2B1-4657-B465-FAB341904BF3Q36765788-ABD4B020-056C-4237-ACEC-BFD0E08F469BQ36970633-7171748C-7262-4170-A976-1628A4FB9499Q37101209-19693357-B107-4EAF-87A0-F3B54E0125BBQ37217978-BDBE522F-97E1-4B85-88FA-400F789DD77BQ37280357-CA33BF90-90B1-4F33-AEAA-8AD07A2DA33FQ37281915-9A07B478-2148-4D20-9609-FDBE9889F0D6Q37518423-5FCEE5D5-7D85-403C-A8EF-AF6C76D52FB4Q37550579-4B57A101-6046-4BFD-B629-07FECE47E783Q37603058-471EF61B-D5EA-4060-9A9F-2810D7A8A417Q38023790-80838E98-BA99-4C2B-86C9-186208A0D1FEQ39890806-B598CBFB-EDBD-4F32-A778-A3BBDB120724Q40198635-A7E88010-70B2-4489-BA01-3CB9B4BFADD6Q41846051-465F1A02-377A-4282-BE3B-55D9A54BC7C4Q41884316-6C3707B0-BDE5-4293-9F30-B43518FBFA71Q45343434-04E17841-BA7F-4D1A-9F96-B5D5E14700CEQ45354756-781F8E4A-35BE-42BA-897A-12125201A08FQ46202364-960C213E-58CA-425B-9B9D-0BBAD2AF5E5FQ48256915-D64DF28D-7FB2-43CF-918B-53EFF818B75FQ50192080-1463AF32-9BB3-49FB-BC58-82F099574D32Q54369334-DD9A1573-5A04-4EF6-8780-4763DDF935B2Q55051367-2E140069-8357-427B-A168-7CE09BD3C543
P2860
Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging potential of thioredo ...... in various disease conditions.
@en
Emerging potential of thioredo ...... in various disease conditions.
@nl
type
label
Emerging potential of thioredo ...... in various disease conditions.
@en
Emerging potential of thioredo ...... in various disease conditions.
@nl
prefLabel
Emerging potential of thioredo ...... in various disease conditions.
@en
Emerging potential of thioredo ...... in various disease conditions.
@nl
P1476
Emerging potential of thioredo ...... in various disease conditions.
@en
P2093
Dipak K Das
Nilanjana Maulik
P304
P356
10.1016/J.BBAGEN.2007.12.008
P407
P577
2008-01-16T00:00:00Z